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to gain 0.5 QALYs. Screening is warranted in hyperten-
sive women despite a high predisposition to breast cancer:
the overall gain of screening in this subset is 0.8 QALYs.
Those women who carry both factor V and prothrombin
mutations should stop HRT after 4.2 years. Multiple-
ways sensitivity analysis showed that in women with 
no thrombophilia the risk of coronary disease or breast
cancer do not inﬂuence the utility of HRT, while the risks
are fundamental in deciding whether to treat women with
multiple thrombophilic defects. Thus, family and per-
sonal history and post-menopausal symptoms do not
deﬁne a risk proﬁle that can really optimize HRT pre-
scription in all the patient subsets. CONCLUSIONS:
According to the available evidence, screening for throm-
bophilia is not helpful in all candidates for HRT, however,
speciﬁc risk proﬁles should prompt the screening as to
allow for a speciﬁc optimization of HRT prescription and
duration.
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OBJECTIVES: Determine the value of the Puregon Pen
compared to the standard syringe treatment for women
undergoing infertility treatment. METHODS: A discrete
choice experiment (DCE) was developed and piloted on
18 women experienced with gonadotrophin injections
with the standard syringe. Based upon responses, the
instrument was revised and after obtaining informed
consent, administered by nurses to a convenience sample
of 60 women with 1 or 2 prior cycles of injected
gonadotrophins for infertility treatment in 6 participating
clinics in France. Attributes in the DCE were “local skin
reactions” and “cost”. Based on these attributes respon-
dents were asked to choose between “continuing with the
syringe” or “switching to the Pen”. The experiment used
an orthogonal in difference design and each subject was
presented with 15 choices. Given cost was included as an
attribute willingness to pay for both the syringe and pen
could be estimated. Information was also collected on
demographics and pain, anxiety and fear of syringe injec-
tions. RESULTS: There were 50 evaluable respondents.
Average age was 33; 69% had 1 previous cycle of infer-
tility treatment, 62% had injections at home by a nurse
and 18% self-injected. 29% indicated the injections were
always or usually painful and 62% feared the injection
would not be done properly if self-injected. The discrete
model analysis indicated a general preference for the Pen
over the syringe and a WTP of €56. CONCLUSION:
Women were capable of choosing between the Pen and
syringe and from this WTP for the different treatment
options was estimated. Based on these results, women
prefer the Pen over the syringe.
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OBJECTIVE: Several studies have presented conﬂicting
reports concerning the relationship between paternal
organic solvent exposure and spontaneous abortions
(SAs). We conducted a meta-analysis to evaluate and
quantify that risk. METHODS: A literature search was
performed on Medline, Toxline, and Embase. We
searched for all original comparative research studies,
published from 1966 to the present (AP 2002), that inves-
tigated pre- and periconceptional paternal organic solvent
exposure and subsequent SA. Two independent reviewers
identiﬁed and extracted the data; disagreements were
resolved by consensus. The Mantel-Haenszel method was
used to calculate summary odds ratios (ORs) with 95%
conﬁdence intervals (CI). Homogeneity of effects was
assessed using chi-square and a funnel plot was used to
examine publication bias. RESULTS: Forty-four studies
were identiﬁed; 39 were excluded (13 examined inappro-
priate exposures, 12 had inappropriate outcomes, 9 were
reviews, 4 had no extractable data, 1 was a duplicate).
Five studies provided useable data, but the exposure
assessment varied considerably. Some studies used only
occupational codes, while others conducted telephone
interviews to insure actual exposure. For the 3 case
control studies with conﬁrmed high exposure to solvents
(n = 91,550), ORs = 1.26(CI 95%: 0.80–1.99). Power
was 87.8%. When all available data (n = 18,800) were
combined, ORs = 1.19 (CI 95%: 1.04–1.35), but effects
were heterogeneous (Chi-square = 56.74, p < 0.001) and
the funnel plot displayed publication bias, as there were
no small negative studies. After adjusting for bias, signif-
icance disappeared (ORs = 0.98, 0.90–1.08). CONCLU-
SION: The risk for spontaneous abortion is not increased
by the paternal occupational exposure to organic sol-
vents. Selective publication of small positive studies may
have falsely exaggerated this risk.
